Although acebutolol (ABT) is almost completely absorbed in the gastrointestinal (GI) tract, oral bioavailability of the drug is low due to extensive first-pass metabolism in the Gl tract and liver, In the present study; bioavailability and pharmacokin...
Although acebutolol (ABT) is almost completely absorbed in the gastrointestinal (GI) tract, oral bioavailability of the drug is low due to extensive first-pass metabolism in the Gl tract and liver, In the present study; bioavailability and pharmacokinetics of ABT was studied in bile duct-bypassed rabbits after oral administration. For ABT the time to reach the plasma peak (Tmax) and mean resident time (MRT) were increased by the treatment. For diacetolol (DAT), a metabolite of ABT area under the plasma concentration-time curve (AUC), T max and plasma half-life were increased by the treatment. These results indicate that oral bioavailability of ABT is associated with the enterohepatic recycling of bile juice components.